Labceutics Launches "Labceutics Connect" Platform
Published: Jun 19, 2012
LONDON--(Marketwire - June 19, 2012) -
Labceutics has partnered with more than 120 leading EU laboratories to provide pharmaceutical and diagnostic companies with a one-stop personalized medicine laboratory partner. The network's focus is on the development and implementation of companion laboratory testing and related services that enable a high return on investment for personalized therapies.
"Being part of a personalized medicine network and having the ability to use a tool like Labceutics Connect enables our biocluster to be on the cutting edge of personalized medicine and to interact more effectively with our peers across the EU," said Jesus María Izco PhD, of CIBER-BBN (Spain). "We are seeing new tests and technology coming to the market every day and we want to ensure the services we provide our community are of the highest quality."
Given the innovation and evolution of personalized medicine on a global level, Labceutics is also partnering with the key stakeholders in the industry including pharmaceutical companies, diagnostic companies, personalized medicine-focused associations, biobanks, biotechnology companies and other healthcare organizations.
Labceutics will have a booth at the ESMO Congress (www.esmo.org), which takes place in Vienna (Austria) between 28 September and 2 October 2012. There will be on-site Labceutics ConnectÔ demos, information about the benefits of joining and leveraging the Labceutics network, and details on the launch of the Labceutics network in Asia.
To obtain more information about the connectivity platform or to meet us at the congress, please contact Jose Luis Ferreiro at: firstname.lastname@example.org.
Labceutics (www.labceutics.com), a division of Diaceutics, supports the integration of pharmaceutical and diagnostic companies through its personalized medicine laboratory network that offers early testing access, quality standards, education and real-time communication across stakeholders to help physicians diagnose, prescribe and monitor care effectively.
For more information contact:
Maria Fe Paz, MSc, PhD
Cellular: +34 670 551 276